• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低i-PTH水平的持续性非卧床腹膜透析患者甲状旁腺抑制的可逆性

Reversibility of parathyroid gland suppression in CAPD patients with low i-PTH levels.

作者信息

Montenegro J, Saracho R, González O, Moina I, Martínez I

机构信息

Nefrología, Hospital de Galdácano, Vizcaya, Spain.

出版信息

Clin Nephrol. 1997 Dec;48(6):359-63.

PMID:9438094
Abstract

The i-PTH response to changes in the peritoneal calcium balance was studied prospectively in a group of 13 stable CAPD patients, who presumably had adynamic bone disease, with low or normal i-PTH values and low aluminum in plasma. Five days after the reduction of dialysate calcium concentration from 1.75 mmol/l to 1 mmol/l, there was a significant elevation in the serum i-PTH. These increased PTH levels returned to baseline values when patients were changed to the 1.75 mmol/l Ca solution (p = 0.004). The changes in i-PTH mirrored the changes in peritoneal calcium balances. These results support the notion that the low or normal levels of i-PTH frequently seen in peritoneal dialysis patients are due to the hypercalcemic effects of the standard peritoneal dialysis solutions; in these patients, the parathyroid hormone production is normal since negative peritoneal balances of calcium are associated with an increase in serum i-PTH.

摘要

前瞻性研究了一组13例稳定的持续性非卧床腹膜透析(CAPD)患者,这些患者可能患有动力缺失性骨病,其血浆全段甲状旁腺激素(i-PTH)值低或正常,且铝含量低,以观察i-PTH对腹膜钙平衡变化的反应。在透析液钙浓度从1.75 mmol/l降至1 mmol/l 5天后,血清i-PTH显著升高。当患者改用1.75 mmol/l钙溶液时,这些升高的甲状旁腺激素水平恢复到基线值(p = 0.004)。i-PTH的变化反映了腹膜钙平衡的变化。这些结果支持以下观点:腹膜透析患者中常见的i-PTH低水平或正常水平是由于标准腹膜透析液的高钙血症作用所致;在这些患者中,甲状旁腺激素的产生是正常的,因为腹膜钙的负平衡与血清i-PTH的增加有关。

相似文献

1
Reversibility of parathyroid gland suppression in CAPD patients with low i-PTH levels.低i-PTH水平的持续性非卧床腹膜透析患者甲状旁腺抑制的可逆性
Clin Nephrol. 1997 Dec;48(6):359-63.
2
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
3
Low calcium peritoneal dialysis solution. Effects on calcium metabolism and bone disease in CAPD patients.
ASAIO J. 1992 Jul-Sep;38(3):M593-5.
4
High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.持续性非卧床腹膜透析(CAPD)患者使用高正常钙(1.35 mmol/l)透析液:对血浆钙、磷和甲状旁腺激素进行有效且安全的长期控制
Nephrol Dial Transplant. 1996 Aug;11(8):1586-91.
5
Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.持续性非卧床腹膜透析中使用低钙溶液(1.0 mmol/L)进行长期透析:对骨矿物质代谢的影响。多中心研究组协作人员
Perit Dial Int. 1996 May-Jun;16(3):260-8.
6
CAPD with low calcium dialysate and calcium carbonate: results of a 24-week study.使用低钙透析液和碳酸钙的持续性非卧床腹膜透析:一项为期24周研究的结果
Adv Perit Dial. 1992;8:356-61.
7
Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.慢性肾功能不全伴低血清甲状旁腺激素或动力缺失性骨病患者在磷负荷期间甲状旁腺激素的变化
Clin Nephrol. 2001 Jul;56(1):35-43.
8
Effect of CAPD and hemodialysis on parathyroid function.持续性非卧床腹膜透析和血液透析对甲状旁腺功能的影响。
Adv Perit Dial. 1996;12:239-44.
9
The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.接受碳酸钙作为磷结合剂的持续性非卧床腹膜透析患者对低钙透析液的需求。
Clin Nephrol. 1993 Aug;40(2):100-5.
10
[The impact of low calcium dialysate (1.25 mmol/l; LCD) on bone metabolism in CAPD patients].
Nihon Jinzo Gakkai Shi. 1998 May;40(4):252-7.

引用本文的文献

1
Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism.西那卡塞长期治疗继发性甲状旁腺功能亢进透析患者前后的骨组织形态计量学研究
Kidney Int. 2015 Apr;87(4):846-56. doi: 10.1038/ki.2014.349. Epub 2014 Oct 22.
2
Biochemical indices of renal osteodystrophy in dialysis patients on the island of Malta.马耳他岛上透析患者肾性骨营养不良的生化指标
Int Urol Nephrol. 2005;37(2):335-40. doi: 10.1007/s11255-004-4653-0.